Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration.

Matragoon S, Al-Gayyar MM, Mysona BA, Abdelsaid MA, Pillai BA, Neet KE, Fagan SC, El-Remessy AB.

Mol Vis. 2012;18:2993-3003. Epub 2012 Dec 14.

2.

Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.

Mohamed IN, Soliman SA, Alhusban A, Matragoon S, Pillai BA, Elmarkaby AA, El-Remessy AB.

Mol Vis. 2012;18:1457-66. Epub 2012 Jun 2.

3.

Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusion.

Guan W, Kozak A, El-Remessy AB, Johnson MH, Pillai BA, Fagan SC.

Transl Stroke Res. 2011 Jun 1;2(2):179-85. doi: 10.1007/s12975-010-0061-1.

4.

Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.

Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB.

Br J Pharmacol. 2011 Sep;164(1):170-80. doi: 10.1111/j.1476-5381.2011.01336.x.

5.

Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line.

El-Remessy AB, Rajesh M, Mukhopadhyay P, Horváth B, Patel V, Al-Gayyar MM, Pillai BA, Pacher P.

Diabetologia. 2011 Jun;54(6):1567-78. doi: 10.1007/s00125-011-2061-4. Epub 2011 Mar 4.

6.

Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].

Al-Gayyar MM, Matragoon S, Pillai BA, Ali TK, Abdelsaid MA, El-Remessy AB.

Diabetologia. 2011 Mar;54(3):669-80. doi: 10.1007/s00125-010-1994-3. Epub 2010 Dec 7. Erratum in: Diabetologia. 2011 Mar;54(3):713.

PMID:
21136036
7.

Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.

Ali TK, Al-Gayyar MM, Matragoon S, Pillai BA, Abdelsaid MA, Nussbaum JJ, El-Remessy AB.

Diabetologia. 2011 Mar;54(3):657-68. doi: 10.1007/s00125-010-1935-1. Epub 2010 Oct 19.

PMID:
20957344
8.

Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.

Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB.

Am J Pathol. 2010 Sep;177(3):1187-97. doi: 10.2353/ajpath.2010.091289. Epub 2010 Jul 22. Erratum in: Am J Pathol. 2015 Jun;185(6):1795-6.

9.

Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.

Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB.

J Pharmacol Exp Ther. 2010 Jan;332(1):125-34. doi: 10.1124/jpet.109.157941. Epub 2009 Oct 8.

PMID:
19815813
10.

Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.

Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB.

Diabetes. 2008 Apr;57(4):889-98. doi: 10.2337/db07-1669. Epub 2008 Feb 19.

11.

Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF.

Pillai A, Dhandapani KM, Pillai BA, Terry AV Jr, Mahadik SP.

Neuropsychopharmacology. 2008 Jul;33(8):1942-51. Epub 2007 Sep 5.

Supplemental Content

Loading ...
Support Center